Pfizer says that it “hit the sweet spot” with its coronavirus vaccine for children ages 5 to 11. CBS News’ Mola Lenghi reports that the company will be applying for emergency use authorization by the end of the month. Then, Dr. Shikha Jain joins CBSN’s Elaine Quijano to discuss more of today’s coronavirus headlines.
